Another mesenchymal stem cell trial, and the first in the U.S.
Cleveland Clinic receives $2.75M grant to study stem cell use in treating MS
December 8, 2009 - The Cleveland Clinic has received a $2.75 million federal grant to study the use of stem cells in treating multiple sclerosis.
The four-year grant from the Department of Defense will fund a 24-patient study to be done by the Center for Stem Cell and Regenerative Medicine, which is made up of investigators from biotech company Athersys Inc., Case Western Reserve University, the Clinic, Ohio State University and University Hospitals Case Medical Center.
In the study, patients with relapsing MS who are still able to walk even though they have moderate to severe disability will have bone marrow removed from their hips. Mesenchymal stem cells then will be grown in a laboratory and inserted into the body to determine whether such a procedure is safe and improves the patient's condition.
http://www.crainscleveland.com/article/ ... /912089977